# Amsflow vs Floatz

Amsflow records 37,303 monthly visits with +72.2% month-over-month growth and Free Trial, Paid pricing. Floatz records 253 monthly visits with -36.8% growth and Contact for Pricing pricing.

| Metric | [Amsflow](https://openaitools.app/tool/amsflow) | [Floatz](https://openaitools.app/tool/floatz-ai) |
| :--- | :--- | :--- |
| Website URL | https://amsflow.com | https://floatz.ai |
| Categories | AI For Finance, AI Research Tool, AI For Data Analytics, AI Assistant | AI Healthcare, AI Research Tool, AI For Data Analytics, AI Report Generator |
| Pricing Model | Free Trial, Paid | Contact for Pricing |
| Monthly Visits | 37,303 | 253 |
| MoM Growth Rate | +72.2% | -36.8% |
| Primary Market | South Korea | Switzerland |
| Direct Visits | 13,426 | 94 |
| Review Score | 4.2 | 3.8 |
| Saved Count | 0 | 17 |
| Supported Platforms | Website | Website |

## Amsflow

Amsflow positions itself as "sleek market research for the curious," combining institutional-grade depth with a deliberately uncluttered interface. The core promise is that everything — screening, charting, backtesting, alerts, portfolio tracking, and dashboards — runs on one set of data, so a screen result and a chart never disagree. The platform covers more than 70,000 global stocks alongside ETFs, funds, indices, cryptocurrencies, and commodities, across 14 markets.

The AI layer is split into two roles. Flow Agent builds things: you describe a strategy or indicator in plain language, and the agent writes it in Amsflow's FlowScript, applies it to the chart, backtests it without look-ahead bias, reviews the results, and iterates for up to six rounds. Lisa handles research: it reads the bars, indicators, and backtest trades on screen, answers comparison and valuation questions, can interpret attached screenshots, and produces X-Ray reports with highlights, anomalies, scorecards, and technical reads. Both are interactive — you can ask follow-ups to add analyst ratings, drop ratios, or track margins in place.

The supporting toolkit is broad rather than shallow. Screener 2.0 blends fundamentals with technicals, 44 candlestick patterns, 16 chart patterns by stage, divergences, and 37 strategies each carrying a backtested win rate. Alerts support up to 10 grouped conditions and route to email, SMS, webhook, Slack, Teams, Discord, or Telegram. Dashboards are built from prompts into widget boards, portfolios support multi-lot positions in nine currencies with six-factor attribution, and there is a separate personal finance side with Monte Carlo retirement projections and a trading journal that scores a "Flow Score" from win rate, profit factor, drawdown, recovery, and consistency.

**Pricing & Plans:** Amsflow offers a free trial alongside paid subscription tiers; feature access such as chart limits, alert capacity, and AI agent usage scales by plan. Check the official pricing page for current figures.

- **Flow Agent strategy builder:** Describe an indicator, screen, or strategy in plain language; Flow Agent writes it in FlowScript, applies it to the chart, backtests it with no look-ahead, and refines it for up to six rounds.
- **Lisa AI research assistant:** Ask questions about the chart in front of you — Lisa reads bars, indicators, and backtest trades, accepts screenshot attachments, and generates X-Ray reports with highlights, anomalies, and scorecards.
- **Screener 2.0 with patterns and signals:** Combine 830+ fundamental and technical metrics with 44 candlestick patterns, 16 chart patterns by stage, 32 divergence filters, and 37 strategies that each show their backtested win rate.
- **Chart engine with backtest and replay:** 19 chart types including Market Profile and Volume Footprint, 74 indicators, 59 drawing tools, bar-by-bar Replay, paper trading, and up to 16 synced chart layouts.
- **Multi-condition alerts and dashboards:** Build alerts with up to 10 bracketed conditions and 60+ indicator types, delivered by email, SMS, webhook, Slack, Teams, Discord, or Telegram; generate widget dashboards directly from a prompt.

**Strengths:** Plain-language strategy creation with immediate backtesting removes most of the scripting barrier; Screening, charting, alerts, and backtesting all run on one engine, so outputs stay consistent; Unusually deep coverage of patterns, divergences, and strategy signals with built-in win rates; Alerts are genuinely flexible, with grouped conditions and delivery to chat platforms and webhooks

**Limitations:** The sheer breadth of features can be overwhelming for a new investor; Advanced functionality such as Flow Agent and multi-condition alerts is gated behind higher-priced plans; Pricing is not published in full on the landing page, so you need to visit the pricing page to compare tiers

[Profile (Markdown)](https://openaitools.app/tool/amsflow.md)

## Floatz

Floatz positions itself as an AI research engine for life-science questions. Rather than relying on manual literature reviews, it indexes and summarises scientific publications so users can interrogate a therapeutic area, a target or a company's science and get a consolidated view in minutes rather than weeks.

The platform is aimed at two overlapping audiences: investors doing scientific due diligence on biotech and life-science assets, and research teams who need fast, cited groundwork on drug targets, pathways and emerging evidence. Results are presented as structured summaries with the underlying papers kept as traceable references.

Floatz does not publish self-serve pricing; the site directs buyers to request access, which is typical of enterprise/investor-grade research tools where seats and data volumes are negotiated. Because capabilities and data coverage evolve quickly, it is worth confirming the current scope of literature coverage directly with the vendor.

**Pricing & Plans:** Contact for pricing — Floatz does not list public plans on its website and directs interested users to get in touch.

- **Scientific literature search and analysis:** Search and analyse large bodies of scientific papers to answer specific research or therapeutic-area questions.
- **Structured summaries with sources:** Distils dense literature into readable, source-linked summaries so findings can be traced back to the original publications.
- **Target and pathway discovery support:** Helps surface high-potential drug targets and relevant biological pathways across large document sets.
- **Due-diligence workflows for investors:** Frames evidence around scientific risk so life-science investors can review a thesis before capital is committed.
- **Built for non-programmers:** A web interface aimed at analysts and researchers rather than bioinformaticians, so no coding or command-line work is required.

**Strengths:** Focuses on life-science evidence rather than generic text, so outputs are framed around targets, pathways and scientific risk; Saves the weeks normally spent on manual literature triage; Aims to keep summaries traceable to source publications, which matters for audit and investment memos; Browser-based, so analysts and investors can use it without a bioinformatics stack

**Limitations:** No public pricing or self-serve trial published on the site, so onboarding likely requires a sales conversation; Coverage and accuracy depend on the literature and data sources it indexes, which are not fully documented publicly; Best suited to life-science questions — it is not a general-purpose research assistant

[Profile (Markdown)](https://openaitools.app/tool/floatz-ai.md)

## Frequently Asked Questions

### How do Amsflow and Floatz compare in monthly traffic?

Amsflow has 37,303 monthly visits, while Floatz has 253. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Amsflow has a month-over-month growth rate of +72.2%; Floatz has -36.8%.

### How does pricing compare?

Amsflow: Free Trial, Paid. Amsflow offers a free trial alongside paid subscription tiers; feature access such as chart limits, alert capacity, and AI agent usage scales by plan. Check the official pricing page for current figures. Floatz: Contact for Pricing. Contact for pricing — Floatz does not list public plans on its website and directs interested users to get in touch.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | A free, AI-powered academic search engine for 240M+ papers across every scientific field | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 2 | [Consensus](https://openaitools.app/tool/consensus) | 6,014,388 | -1.2% | Freemium | AI academic search engine for peer-reviewed science | [.md](https://openaitools.app/tool/consensus.md) |
| 3 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | AI research platform for reading, understanding and writing scientific papers | [.md](https://openaitools.app/tool/scispace.md) |
| 4 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | AI research assistant for evidence-based literature review and synthesis | [.md](https://openaitools.app/tool/elicit.md) |
| 5 | [LuxAlgo](https://openaitools.app/tool/luxalgo) | 985,376 | +9.8% | Freemium, Free Trial, Paid | AI trading indicators, real-trade orderflow and charts in one platform | [.md](https://openaitools.app/tool/luxalgo.md) |
| 6 | [MacroMicro](https://openaitools.app/tool/macromicro) | 928,258 | +22.5% | Freemium, Paid | Global macro data and AI research platform for smarter economic decisions | [.md](https://openaitools.app/tool/macromicro.md) |
| 7 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | AI answers grounded in 300M+ scholarly full texts | [.md](https://openaitools.app/tool/scite.md) |
| 8 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 9 | [Aime](https://openaitools.app/tool/aime) | 260,428 | +11.4% | Freemium | AI investing copilot for stock research, screening and market signals | [.md](https://openaitools.app/tool/aime.md) |
| 10 | [Danelfin](https://openaitools.app/tool/danelfin-com) | 216,830 | -11.1% | Freemium | AI-driven stock scores that rank every pickable stock by probability of beating the market | [.md](https://openaitools.app/tool/danelfin-com.md) |

---
Source: https://openaitools.app/compare/amsflow-vs-floatz-ai

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)